Evaluation of the long-term safety and effectiveness of tadalafil once daily in Chinese men with erectile dysfunction: interim results of a multicenter, randomized, open-label trial

Once-daily tadalafil administration has been well established; however, studies about tadalafil once-daily treatment in the Chinese population are lacking. In this phase 4, postmarketing study, we ascertained the long-term safety and effectiveness of tadalafil 2.5 mg and 5.0 mg once daily in Chinese...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Hui, Zhao, Lian-Ming, Lin, Hao-Cheng, Yan, Su, Liu, Ji-Hong, Zhu, Zhao-Hui, Luo, Jin-Dan, Dai, Yu-Tian, Li, Fu-Biao, Lou, Ying, Zhang, Zhi-Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219303/
https://www.ncbi.nlm.nih.gov/pubmed/30004039
http://dx.doi.org/10.4103/aja.aja_47_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219303/
https://www.ncbi.nlm.nih.gov/pubmed/30004039
http://dx.doi.org/10.4103/aja.aja_47_18

Ejemplares similares